Dendritic cell based immunotherapy for HIV is safe and immunogenic: results of a phase I/II clinical trial

Brenda De Keersmaecker, A.l. De Goede, S. Allard, M.e. Van Der Ende, P. Lacor, Carel A. Van Baalen, Kris Thielemans, Ab Osterhaus, Joeri Aerts, Rob A. Gruters

    Onderzoeksoutput: Meeting abstract (Book)Research

    Originele taal-2English
    TitelDutch Annual Virology Symposium
    StatusPublished - 2010

    Citeer dit